_version_ |
1797350564728668160
|
collection |
DOAJ
|
first_indexed |
2024-03-08T12:46:47Z
|
format |
Article
|
id |
doaj.art-d1981c02166243f2a5e4e46aa533f30c
|
institution |
Directory Open Access Journal
|
issn |
1932-6203
|
language |
English
|
last_indexed |
2024-03-08T12:46:47Z
|
publishDate |
2024-01-01
|
publisher |
Public Library of Science (PLoS)
|
record_format |
Article
|
series |
PLoS ONE
|
spelling |
doaj.art-d1981c02166243f2a5e4e46aa533f30c2024-01-21T05:30:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01191Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trialhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10796039/?tool=EBI
|
spellingShingle |
Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
PLoS ONE
|
title |
Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
|
title_full |
Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
|
title_fullStr |
Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
|
title_full_unstemmed |
Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
|
title_short |
Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
|
title_sort |
retraction 2 day versus c reactive protein guided antibiotherapy with levofloxacin in acute copd exacerbation a randomized controlled trial
|
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10796039/?tool=EBI
|